Aslan Pharmaceuticals Ltd ADR
$ 0.60
0.00%
03 Dec - close price
- Market Cap 1,697,000 USD
- Current Price $ 0.60
- High / Low $ 0.60 / 0.60
- Stock P/E N/A
- Book Value -7.70
- EPS -16.00
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.54 %
- ROE -4.27 %
- 52 Week High 0.00
- 52 Week Low 0.00
About
ASLAN Pharmaceuticals Limited (ASLN) is a Singapore-based biopharmaceutical company focused on the development of innovative immunotherapy solutions to address significant unmet medical needs in oncology and autoimmune diseases. The company has a robust pipeline of clinical-stage drug candidates, reflecting its commitment to transformative research and development aimed at improving patient outcomes. With a strategic focus on leveraging its specialized expertise, ASLAN is well-positioned to navigate the evolving biopharmaceutical landscape and capitalize on emerging market opportunities.
Analyst Target Price
$72.00
Quarterly Earnings
| Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2024-04-12 | 2024-01-10 | 2023-10-27 | 2023-08-11 | 2023-04-28 | 2023-03-24 | 2022-10-28 | 2022-08-12 | 2022-04-27 | 2022-03-25 | 2021-10-26 | 2021-08-06 |
| Reported EPS | -0.78 | -0.78 | -0.56 | -0.11 | -1.29 | -1.04 | -0.8 | -0.95 | -0.95 | -0.8 | -0.6 | -0.35 |
| Estimated EPS | -0.65 | -0.65 | -0.78 | -0.8 | -4.05 | -0.89 | -0.95 | -0.6 | -0.52 | -0.72 | -0.65 | -0.55 |
| Surprise | -0.13 | -0.13 | 0.22 | 0.69 | 2.76 | -0.15 | 0.15 | -0.35 | -0.43 | -0.08 | 0.05 | 0.2 |
| Surprise Percentage | -20% | -20% | 28.2051% | 86.25% | 68.1481% | -16.8539% | 15.7895% | -58.3333% | -82.6923% | -11.1111% | 7.6923% | 36.3636% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
